Report Highlights
- The U.S. market for ultrafiltration technologies was worth $882 million in 2009 and will reach $932 million by the end of 2010. By 2015, the market is estimated to be valued at $1.2 billion, a compound annual growth rate (CAGR) of 5.7%.
- Hemodialysis is the largest ultrafiltration application market, with 52% market share in 2010. The market for hemodialyzers will reach $485 million by the end of 2010 and $626 million by 2015, a compound annual growth rate (CAGR) of 5.2%.
- The biotechnology sector is expected to continue growing robustly over the next 5 years. The market for UF products used in biotech research, biopharmaceuticals processing, and compendial water production is worth approximately $80 million in 2010. Growth in the market from 2010 to 2015 is forecast to rise at a compound annual growth rate (CAGR) of 10.2%, for a value of $130 million.
INTRODUCTION
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers.
Report Highlights
- The total U.S. market value for ultrafiltration membranes was worth $579 million in 2005 and $635 million in 2006. At a compound annual growth rate (CAGR) of 7.4%, this market will reach $908 million by 2011.
- Broken down between bioseparations/medical and municipal/industrial applications, the market remains largely split down the middle throughout the forecast period. Bioseparations will grow slightly to 52% of the total market value throughout the forecast period, while municipal/industrial applications will drop slightly to 47%
- Bioseparation/medical applications have the highest CAGR throughout the forecast period. In 2006 this sector of the market was worth $324 million and will grow to $476 million by 2011, a CAGR of 8.0%.
Report Highlights
-
The market for ultrafiltration will rise at an average annual growth rate (AAGR) of 9.7% from $458 million in 2002 to $727 million in 2007.
-
Profitable new applications are developing in separations needed for neutraceuticals manufacture, a rapidly growing sector.
-
The phase-out of reusable dialyzers, increased use of more expensive synthetic membranes and an expanding patient population should continue to grow the dialysis market.
-
Potable water production potentially is a very large market for UF membranes Municipal wastewater recycling, using UF, is gaining attention for nonpotable reuse in irrigation and groundwater recharge; the notion that treated wastewater can be recycled as potable also is advancing.
Related Reports
Recent Reports
Major Reverse Osmosis System Components for Water Treatment: The Global Market
The global market for RO system components is expected to grow from $18.8 billion in 2024 and is projected to reach $32.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.
Ultrafiltration Membranes: Technologies and Global Markets
The global market for ultrafiltration membranes was valued at $4.9 billion in 2023. The market is expected to grow from $5.2 billion in 2024 to $8.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2029.
Pharmaceutical Filtration: Global Markets
The global market for pharmaceutical filtration was valued at $10.4 billion in 2023. The market is estimated to grow from $11.4 billion in 2024 to $18.1 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2029.
Water Filtration: Global Markets
The global market for water filtration is expected to grow from $10.5 billion in 2024 and is projected to reach $19.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2024 to 2029.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $17.4 billion in 2023 to reach $25.7 billion by 2028, at a compound annual growth rate (CAGR) of 8.1% from 2023 through 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More